Download Citation
Article Source:
Safety, Adherence and Acceptability of Intermittent Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis (PrEP) among HIV-Uninfected Ugandan Volunteers Living in HIV-Serodiscordant Relationships: A Randomized, Clinical Trial
Kibengo FM,
Ruzagira E,
Katende D,
Bwanika AN,
Bahemuka U,
et al.
(2013)
Safety, Adherence and Acceptability of Intermittent Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis (PrEP) among HIV-Uninfected Ugandan Volunteers Living in HIV-Serodiscordant Relationships: A Randomized, Clinical Trial.
PLOS ONE 8(9): e74314.
https://doi.org/10.1371/journal.pone.0074314